Technical Analysis for ESPR - Esperion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 45.035 -1.04% -0.48
ESPR closed down 2.65 percent on Friday, July 12, 2019, on 1.16 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Earnings due: Aug 1

*** please verify all earnings dates ***
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ESPR trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish -1.04%
200 DMA Support Bullish -3.67%
200 DMA Support Bullish -5.25%
Doji - Bearish? Reversal -5.25%
Crossed Above 200 DMA Bullish -4.77%
NR7 Range Contraction -4.77%
Fell Below 200 DMA Bearish -3.21%
200 DMA Support Bullish -4.65%
Lower Bollinger Band Walk Weakness -4.65%
Up 3 Days in a Row Strength -4.65%

Older signals for ESPR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Its products include ETC-1002, an oral molecule therapy that is in Phase IIa clinical trials to treat lipid and carbohydrate metabolic pathways; ESP41091, which is in pre-clinical trials for type 2 diabetes and obesity treatment; and 4WF, a synthetic therapy that is in pre-clinical trials to reverse the deleterious effects of atherosclerosis. The company is based in Plymouth, Michigan.
Biopharmaceutical Medical Specialties Diabetes Obesity Cardiology Cholesterol Gabaa Receptor Positive Allosteric Modulators Low Density Lipoprotein Lipids Lipoproteins Atherosclerosis
Is ESPR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jun 26 Esperion closes $200M funding deal
Jun 26 Esperion and Oberland Capital Announce $200 Million Funding Agreement
Jun 19 Have Insiders Been Buying Esperion Therapeutics, Inc. (NASDAQ:ESPR) Shares This Year?
Jun 7 Esperion Therapeutics (ESPR) Down 5.6% Since Last Earnings Report: Can It Rebound?
May 30 Esperion Announces the Appointment of Tracy M. Woody to Board of Directors
May 29 Biotech Stocks Clobbered As Two Slammed With Sell Ratings
May 29 Benzinga's Top Upgrades, Downgrades For May 29, 2019
May 27 Esperion Aims for the First Approved Non-Statin Cholesterol Reducer
May 22 Esperion Is The One To Watch, After FDA Deems Advisory Panel Is Not Needed
May 10 Esperion to Participate in Upcoming Investor Conferences
See more ESPR news...
Indicators
Indicator Value
52 Week High 60.99
52 Week Low 36.06
Average Volume 499,796
200-Day Moving Average 46.6447
50-Day Moving Average 48.9656
20-Day Moving Average 48.262
10-Day Moving Average 46.694
Average True Range 1.72
ADX 16.12
+DI 14.8707
-DI 23.809
Chandelier Exit (Long, 3 ATRs ) 47.54
Chandelier Exit (Short, 3 ATRs ) 49.91
Upper Bollinger Band 51.8306
Lower Bollinger Band 44.6934
Percent B (%b) 0.11
BandWidth 14.788446
MACD Line -0.7205
MACD Signal Line -0.477
MACD Histogram -0.2435
Fundamentals Value
Market Cap 1.03 Billion
Num Shares 22.6 Million
EPS -5.77
Price-to-Earnings (P/E) Ratio -7.89
Price-to-Sales 0.00
Price-to-Book 6.37
PEG Ratio -4.32
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.67
Resistance 3 (R3) 47.87 47.35 47.31
Resistance 2 (R2) 47.35 46.80 47.25 47.19
Resistance 1 (R1) 46.43 46.46 46.17 46.23 47.07
Pivot Point 45.91 45.91 45.78 45.81 45.91
Support 1 (S1) 44.99 45.36 44.73 44.79 43.95
Support 2 (S2) 44.47 45.02 44.37 43.83
Support 3 (S3) 43.55 44.47 43.71
Support 4 (S4) 43.35